Can you take Ghrelin and Kisspeptin-10 together?

There is no specific, well-documented interaction rule for combining Ghrelin and Kisspeptin-10 in the aggregated research reviewed. Combining peptides should only be considered under professional supervision. This is not medical advice.

Which is better researched, Ghrelin or Kisspeptin-10?

Ghrelin is currently investigational (in trials) and Kisspeptin-10 is fda-approved. "Better researched" depends on your research goal — review each profile's cited sources.

Performance & Growth Hormone · Comparison

Ghrelin vs Kisspeptin-10

Q: What is the difference between Ghrelin and Kisspeptin-10?

Ghrelin: Endogenous 28-amino acid peptide secreted primarily by the stomach that functions as both the primary hunger signal and a potent growth hormone secretagogue. The n-octanoyl modification at Ser-3 (acylated form) is required for GHS-R1a receptor binding and GH-stimulating activity. Understanding ghrelin explains the mechanism behind the entire GHRP class of research peptides. Kisspeptin-10: Kisspeptin-10 is the biologically active 10-amino acid C-terminal fragment of kisspeptin, a neuropeptide that acts as the master regulator of the hypothalamic-pituitary-gonadal (HPG) axis. By activating KISS1R (GPR54) in the hypothalamus, it triggers pulsatile GnRH release, which drives LH, FSH, and downstream testosterone and estrogen production. It is the upstream signal that 'turns on' the reproductive axis — with research applications spanning fertility, hypogonadism, post-cycle therapy support, and age-related hormonal decline. Both are in the Performance & Growth Hormone category but differ in mechanism, dosing, and research evidence — see the full comparison.

A neutral, side-by-side comparison of two performance & growth hormone peptides — their mechanisms, dosing ranges, administration routes, side effects, and research evidence. For research and educational purposes only.

Ghrelin

Investigational (in trials)

Endogenous 28-amino acid peptide secreted primarily by the stomach that functions as both the primary hunger signal and a potent growth hormone secretagogue. The n-octanoyl modification at Ser-3 (acylated form) is required for GHS-R1a receptor binding and GH-stimulating activity. Understanding ghrelin explains the mechanism behind the entire GHRP class of research peptides.

Full profile

Kisspeptin-10

FDA-approved

Kisspeptin-10 is the biologically active 10-amino acid C-terminal fragment of kisspeptin, a neuropeptide that acts as the master regulator of the hypothalamic-pituitary-gonadal (HPG) axis. By activating KISS1R (GPR54) in the hypothalamus, it triggers pulsatile GnRH release, which drives LH, FSH, and downstream testosterone and estrogen production. It is the upstream signal that 'turns on' the reproductive axis — with research applications spanning fertility, hypogonadism, post-cycle therapy support, and age-related hormonal decline.

Full profile

	Ghrelin	Kisspeptin-10
Category	Performance & Growth Hormone	Performance & Growth Hormone
Also known as	GHRL, growth hormone-releasing peptide endogenous, ghrelinergic peptide, acyl ghrelin	KP-10, Metastin(112-121), KISS1R agonist
Evidence	Investigational (in trials)	FDA-approved
Dosing range	0.5mcg/kg–2mcg/kg mcg/kg, IV or SC bolus; endogenous levels peak pre-meal	50mcg–250mcg mcg, 1–2x daily (pulsatile administration is important — avoid continuous infusion)
Administration	Intravenous (research), Subcutaneous injection	Subcutaneous injection, Intranasal, Intravenous (clinical studies — produces most reliable LH pulses)
Key side effects	Appetite stimulation, Transient hyperglycemia, Water retention, GH pulse stimulation	Generally well-tolerated in clinical trials, Nausea (mild, uncommon), Potential for over-stimulation of the HPG axis at high doses (rarely significant), Theoretical desensitization with continuous (non-pulsatile) dosing
Cited sources	2 references	3 references

Key differences

Evidence level differs: Ghrelin is investigational (in trials), while Kisspeptin-10 is fda-approved.
Administration: Ghrelin — Intravenous (research), Subcutaneous injection; Kisspeptin-10 — Subcutaneous injection, Intranasal, Intravenous (clinical studies — produces most reliable LH pulses).
Dosing units differ: Ghrelin is dosed in mcg/kg, Kisspeptin-10 in mcg — they operate at different scales.
Frequency: Ghrelin is typically IV or SC bolus; endogenous levels peak pre-meal; Kisspeptin-10 is 1–2x daily (pulsatile administration is important — avoid continuous infusion).
Research depth: this profile cites 2 sources for Ghrelin vs 3 for Kisspeptin-10.

How each works

Ghrelin

Ghrelin was discovered in 1999 as the endogenous ligand for the GHS-R1a receptor. Its acylated form activates GH release from the pituitary, stimulates appetite via NPY/AgRP hypothalamic neurons, and modulates energy homeostasis and fat storage. The des-acyl form (majority of circulating ghrelin) lacks GHS-R1a activity but has independent cardiovascular and cellular effects.

Kisspeptin-10

Kisspeptin neurons in the arcuate nucleus form the pulse generator for GnRH secretion — without kisspeptin signaling, reproductive function ceases. Human clinical trials confirm that IV kisspeptin-10 produces rapid, dose-dependent LH pulses in both males and females, restoring hormonal function in hypogonadotropic hypogonadism. Kisspeptin-54 (the longer form) has been studied in human fertility treatments with successful outcomes. Unlike direct LH/FSH administration, kisspeptin works upstream at the hypothalamus, preserving the natural pulsatile release pattern and avoiding receptor desensitization associated with continuous GnRH agonists.

Read the full Ghrelin profile Read the full Kisspeptin-10 profile

This comparison aggregates public research and structured profile data for informational purposes only. It is not medical advice and does not recommend either compound for human use. Consult a qualified healthcare provider before considering any peptide.